Chad N. White - 29 Dec 2022 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Chief Financial Officer
Signature
/s/ Chad N. White
Issuer symbol
SNOA
Transactions as of
29 Dec 2022
Net transactions value
$0
Form type
4
Filing time
30 Dec 2022, 16:02:55 UTC
Previous filing
12 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNOA Stock option (right to buy) Award +9,753 +195% 14,753 29 Dec 2022 Common Stock 9,753 $1.08 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest one third each on 12/29/2023, 12/29/2024 and 12/29/2025, or upon change of control.
F2 The options were awarded and granted to Mr. White for services performed as part of the Company's annual grant of stock options.